Trupanion Beheer

Beheer criteriumcontroles 4/4

Trupanion's CEO is Margi Tooth, appointed in Aug 2024, has a tenure of less than a year. total yearly compensation is $964.59K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth $5.46M. The average tenure of the management team and the board of directors is 4.3 years and 10.4 years respectively.

Belangrijke informatie

Margi Tooth

Algemeen directeur

US$964.6k

Totale compensatie

Percentage CEO-salaris	37.1%
Dienstverband CEO	less than a year
Eigendom CEO	0.2%
Management gemiddelde ambtstermijn	4.3yrs
Gemiddelde ambtstermijn bestuur	10.4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Margi Tooth's beloning veranderd ten opzichte van Trupanion's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$13m
Jun 30 2024	n/a	n/a	-US$19m
Mar 31 2024	n/a	n/a	-US$27m
Dec 31 2023	US$965k	US$358k	-US$45m
Sep 30 2023	n/a	n/a	-US$52m
Jun 30 2023	n/a	n/a	-US$61m
Mar 31 2023	n/a	n/a	-US$61m
Dec 31 2022	US$5m	US$300k	-US$45m
Sep 30 2022	n/a	n/a	-US$42m
Jun 30 2022	n/a	n/a	-US$36m
Mar 31 2022	n/a	n/a	-US$32m
Dec 31 2021	US$5m	US$300k	-US$36m
Sep 30 2021	n/a	n/a	-US$32m
Jun 30 2021	n/a	n/a	-US$28m
Mar 31 2021	n/a	n/a	-US$17m
Dec 31 2020	US$1m	US$300k	-US$6m
Sep 30 2020	n/a	n/a	-US$2m
Jun 30 2020	n/a	n/a	US$2m
Mar 31 2020	n/a	n/a	-US$2m
Dec 31 2019	US$1m	US$240k	-US$2m
Sep 30 2019	n/a	n/a	-US$3m
Jun 30 2019	n/a	n/a	-US$2m
Mar 31 2019	n/a	n/a	-US$743k
Dec 31 2018	US$816k	US$240k	-US$927k

Compensatie versus markt: Margi's total compensation ($USD964.59K) is below average for companies of similar size in the UK market ($USD2.14M).

Compensatie versus inkomsten: Margi's compensation has been consistent with company performance over the past year.

CEO

Margi Tooth (45 yo)

less than a year

Tenure

US$964,594

Compensatie

Ms. Margaret Tooth, also known as Margi, was President at Trupanion, Inc. since February 2022 until 2024 and serves as its Director since July 2024 and also serves as its Chief Executive Officer since Augu...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Darryl Graham Rawlings	Founder & Chair of the Board	24.8yrs	US$321.90k	1.49% $ 34.4m
Margaret Rosemary Tooth	President	less than a year	US$964.59k	0.24% $ 5.5m
Fawwad Qureshi	Chief Finance Officer	1.2yrs	US$1.72m	0% $ 0
John Gallagher	Chief Operating Officer	less than a year	US$588.79k	0.051% $ 1.2m
Steve Weinrauch	Executive Vice President of North America & Veterinary Strategy	9.6yrs	US$599.63k	0.14% $ 3.3m
Wei Li	Senior VP of Finance & Corporate Controller	1.2yrs	US$600.41k	0.017% $ 387.9k
Brenna McGibney	Chief Administrative Officer	1.8yrs	geen gegevens	0.011% $ 250.0k
Laura Bainbridge	Head of Investor Relations	4.8yrs	geen gegevens	geen gegevens
Christopher Kearns	Chief Legal Officer	no data	geen gegevens	geen gegevens
Bradley Lamb	Head of Conversion	4.3yrs	geen gegevens	geen gegevens
Emily Dreyer	Senior Vice President of Channel Growth	4.3yrs	US$2.39m	0.066% $ 1.5m
Shawn McWashington	Head of Corporate Group Benefits	4.3yrs	geen gegevens	geen gegevens

4.3yrs

Gemiddelde duur

49.5yo

Gemiddelde leeftijd

Ervaren management: 0LH0's management team is considered experienced (4.3 years average tenure).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Darryl Graham Rawlings	Founder & Chair of the Board	24.8yrs	US$321.90k	1.49% $ 34.4m
Margaret Rosemary Tooth	President	less than a year	US$964.59k	0.24% $ 5.5m
Jacqueline Davidson	Independent Director	6.2yrs	US$155.88k	0.034% $ 788.7k
Murray Low	Lead Independent Director	18.6yrs	US$155.88k	0.32% $ 7.3m
Howard Rubin	Independent Director	14.7yrs	US$155.88k	0.54% $ 12.5m
Paulette Dodson	Independent Director	1.6yrs	US$93.16k	0.015% $ 350.2k
Bill Williams	Member of Veterinary Advisory Board	no data	geen gegevens	geen gegevens
Robert Totman	Member of Veterinary Advisory Board	no data	geen gegevens	geen gegevens
I. Prior	Member of Veterinary Advisory Board	no data	geen gegevens	geen gegevens
Diane Levitan	Member of Veterinary Advisory Board	no data	geen gegevens	geen gegevens
Jim Amyx	Member of Veterinary Advisory Board	no data	geen gegevens	geen gegevens
John Basterfield	Member of Veterinary Advisory Board	no data	geen gegevens	geen gegevens

10.4yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: 0LH0's board of directors are seasoned and experienced ( 10.4 years average tenure).

Trupanion Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Founder recently bought US$500k worth of stock

Trupanion, Inc. Announces Chief Executive Officer Changes

Daniel “Dan” Levitan and Zay Satchu, Members of the Board of Directors Will Not Stand for Re-Election of Trupanion, Inc

Insider recently sold US$266k worth of stock

Trupanion, Inc. Appoints Richard Enthoven as an Independent Director

Trupanion, Inc. Announces Appointment of Fawwad Qureshi as Chief Financial Officer on September 25, 2023

Recent updates

Third quarter 2024 earnings released: EPS: US$0.034 (vs US$0.097 loss in 3Q 2023)

Trupanion, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Forecast to breakeven in 2025

New minor risk - Profitability

Forecast to breakeven in 2025

Second quarter 2024 earnings released: US$0.14 loss per share (vs US$0.33 loss in 2Q 2023)

New minor risk - Profitability

Trupanion, Inc. to Report Q2, 2024 Results on Aug 08, 2024

No longer forecast to breakeven

Founder recently bought US$500k worth of stock

Forecast to breakeven in 2026

First quarter 2024 earnings released: US$0.16 loss per share (vs US$0.60 loss in 1Q 2023)

Trupanion, Inc. Announces Chief Executive Officer Changes

Trupanion Introduces truInsights: A Pet Health Data Initiative

Trupanion Introduces truInsights: A Pet Health Data Initiative

Trupanion, Inc. to Report Q1, 2024 Results on May 02, 2024

Daniel “Dan” Levitan and Zay Satchu, Members of the Board of Directors Will Not Stand for Re-Election of Trupanion, Inc

Forecast breakeven date moved forward to 2025

New minor risk - Shareholder dilution

Full year 2023 earnings released: US$1.08 loss per share (vs US$1.10 loss in FY 2022)

Trupanion, Inc. to Report Q4, 2023 Results on Feb 15, 2024

Forecast to breakeven in 2026

Insider recently sold US$266k worth of stock

Trupanion, Inc. Appoints Richard Enthoven as an Independent Director

New major risk - Share price stability

Third quarter 2023 earnings released: US$0.097 loss per share (vs US$0.32 loss in 3Q 2022)

Trupanion, Inc. to Report Q3, 2023 Results on Nov 02, 2023

Trupanion, Inc. Announces Appointment of Fawwad Qureshi as Chief Financial Officer on September 25, 2023

Second quarter 2023 earnings released: US$0.33 loss per share (vs US$0.33 loss in 2Q 2022)

Trupanion, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Trupanion, Inc. Announces Appointment of Max Brodn as Independent Director

First quarter 2023 earnings released: US$0.60 loss per share (vs US$0.22 loss in 1Q 2022)

Independent Director & Consultant recently sold US$206k worth of stock

Trupanion, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2023

Full year 2022 earnings released: US$1.10 loss per share (vs US$0.89 loss in FY 2021)

Trupanion, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Trupanion, Inc., Annual General Meeting, Jun 07, 2023

Insufficient new directors

Third quarter 2022 earnings released: US$0.32 loss per share (vs US$0.17 loss in 3Q 2021)

Trupanion, Inc. (NasdaqGM:TRUP) entered into a definitive agreement to acquire PetExpert Europe s.r.o..

Trupanion, Inc. (NasdaqGM:TRUP) has signed a definitive agreement to acquire Royal Blue s.r.o.

Trupanion, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Founder recently sold US$246k worth of stock

Trupanion, Inc. (NasdaqGM:TRUP) acquired Smart Paws GmbH.

Insider recently sold US$217k worth of stock

President recently sold US$497k worth of stock

Trupanion Appoints Brenna McGibney as Chief People Officer

Second quarter 2022 earnings released: US$0.33 loss per share (vs US$0.23 loss in 2Q 2021)

Insufficient new directors

Trupanion, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Trupanion, Inc. Announces Management Changes

President recently sold US$67k worth of stock

First quarter 2022 earnings released: US$0.22 loss per share (vs US$0.31 loss in 1Q 2021)

Insufficient new directors

Trupanion, Inc. to Report Q1, 2022 Results on Apr 28, 2022

Trupanion, Inc., Annual General Meeting, Jun 08, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Trupanion, Inc. Announces Executive Changes

Trupanion, Inc. to Report Q4, 2021 Results on Feb 16, 2022

Independent Director & Consultant recently sold US$192k worth of stock

Third quarter 2021 earnings released: US$0.17 loss per share (vs US$0.072 loss in 3Q 2020)

Insufficient new directors

Insufficient new directors

Second quarter 2021 earnings released: US$0.23 loss per share (vs US$0.038 profit in 2Q 2020)

Independent Director H. Hays Lindsley has left the company

Independent Director Robin Ferracone has left the company

Independent Director recently bought US$1.4m worth of stock

First quarter 2021 earnings released: US$0.31 loss per share (vs US$0.032 loss in 1Q 2020)

Robin Ferracone and Hays Lindsley, Each A Member of the Board of Directors of Trupanion, Inc., Notifies to Not Stand for Re-Election